Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Altimmune Announced That It Has Announced That It Has Enrolled The First Patient In Its Multinational Phase 2 Clinical Trial Of HepTcell


Benzinga | Dec 30, 2020 08:20AM EST

Altimmune Announced That It Has Announced That It Has Enrolled The First Patient In Its Multinational Phase 2 Clinical Trial Of HepTcell






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC